• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Alimera raises $37.5M in private placement

February 18, 2014 By drugdelivery

Alimera raises $37.5M in private placement

Alimera Sciences (NSDQ:ALIM) raised $37.5 million in a recent funding round, planning on using the funds to support general corporate operations.

The Atlanta, Ga.-based device maker sold about 6.3 million newly issued shares of common stock in a private placement funding round that drew 21 unnamed investors, according to an SEC filing.

The funds will go toward "general corporate and working capital purposes" for Alimera, which has suffered some significant setbacks in pursuing regulatory approval for its Iluvien drug-device combination. The company landed a major win late last year when the FDA agreed to let the company skip past the usual advisory panel committee meeting and head straight to final FDA review.

The Iluvien product, which Alimera licenses from pSivida (NSDQ:PSDV), has been thrice rejected by FDA regulators, but the drug-device combination product has come a long way. The product won CE Mark approval in the European Union last year with indication cataract surgery patients who don’t respond to standard treatment for diabetic macular edema.

ALIM shares were down 2.4% today, trading at $6.51 as of about 3 p.m.

Filed Under: Drug-Device Combinations Tagged With: Alimera Sciences

IN CASE YOU MISSED IT

  • Tandem Diabetes Care wins CE mark for Mobi insulin pump with Control-IQ+ technology
  • Glooko adds chief strategy officer to chief medical officer’s title
  • Cordis launches 10,000-patient registry for drug-eluting balloon
  • Senseonics opens $50M public offering, $25M private placement with Abbott
  • Study links Abbott CGM use to lower risk of hospitalizations due to heart complications

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS